FDA Inspection 1198954 — Rommelag CDMO GmbH
The FDA completed an inspection of Rommelag CDMO GmbH on February 9, 2023 in Sulzbach-Laufen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 9, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Sulzbach-Laufen (Germany)